Maternal medicine in the COVID era
Sophie Relph1, Shakila Thangaratinam2
1Royal College of Obstetricians and Gynaecologists, 10 -18 Union Street, London, SE1 1SZ, UK.
Abstract:
The coronavirus disease-19 (COVID-19) pandemic has directly and indirectly impacted pregnant women with co-morbidities or antenatal medical complications, through vulnerability to the severe effects of COVID-19 and service reconfiguration. Women with diabetes or hypertension in pregnancy are at higher risk of admission to intensive care, need for invasive ventilation and death from COVID-19. Suggested service modifications specific to maternal medicine services include home measurement of blood glucose or blood pressure, the use of risk calculators, adaptations to screening criteria for gestational diabetes and monitoring of obstetric cholestasis. Neither the added risk of COVID-19 on pregnant women with medical comorbidities nor the impact of maternal medicine service modifications has yet been established.
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Mitral Valve Prolapse III: Nursing Management
Myocarditis III: Medical Management
Mitral Stenosis III: Medical Management
Factors Affecting Drug Response: Overview
Acute Coronary Syndrome IV: Interprofessional Care


